{
  "meta": {
    "title": "Integrated_Mini_Test_7_-_Pathology",
    "url": "https://brainandscalpel.vercel.app/integrated-mini-test-7-pathology-1866d95c.html",
    "scrapedAt": "2025-11-30T12:47:02.889Z"
  },
  "questions": [
    {
      "text": "The autopsy of a 60-year-old man who died of a respiratory illness revealed the following findings on the pleura. What was the most likely occupation of this man?",
      "choices": [
        {
          "id": 1,
          "text": "Insulation industry"
        },
        {
          "id": 2,
          "text": "Coal mining"
        },
        {
          "id": 3,
          "text": "Sandblasting"
        },
        {
          "id": 4,
          "text": "Sugar cane factory"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given&nbsp;clinical scenario and the image showing pleural plaques are suggestive of <strong>asbestosis</strong>. Asbestosis develops due to&nbsp;<strong>prolonged inhalation of asbestos, </strong>which is common in the<strong> insulation industry.&nbsp;</strong></p>\n<p>Pleural plaques are the most common manifestation of asbestos exposure. They are well-circumscribed plaques of dense collagen, often containing calcium. They develop most frequently on the<strong>&nbsp;parietal pleura</strong> and over the<strong> domes </strong>of the<strong> diaphragm</strong>.&nbsp;They do not contain asbestos bodies, and only rarely occur in persons without prior asbestos exposure.</p>\n<div class=\"page\" title=\"Page 697\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Asbestos occurs in two distinct forms - <strong>s</strong><strong>erpentine chrysotile</strong>&nbsp;(more common) and&nbsp;<strong>amphibole</strong>&nbsp;(more pathogenic). Exposure may result in the following conditions:</p>\n</div>\n</div>\n</div>\n</div>\n<ul>\n<li>Localized fibrous&nbsp;plaques&nbsp;or, rarely, diffuse pleural fibrosis</li>\n<li><strong>Pleural effusions</strong></li>\n<li>Parenchymal&nbsp;<strong>interstitial fibrosis</strong>&nbsp;(asbestosis)</li>\n<li><strong>Lung carcinoma</strong></li>\n<li><strong>Mesotheliomas</strong></li>\n<li>Extrapulmonary neoplasms including laryngeal, ovarian, and colon carcinomas</li>\n</ul>\n<p>The image below shows fibrous pleural plaques seen on the diaphragmatic pleural surface in asbestosis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/cb3c2adac5f146e8a31fd87d3b9e240dx800x537.JPEG\" alt=\"Explanation Image\"><p>Other options-</p>\n<p>Option B:&nbsp;<strong>Anthracosis/c</strong><strong>oal workers' pneumoconiosis&nbsp;</strong>is&nbsp;a pulmonary condition seen in coal miners. The inhaled carbon pigment is engulfed by alveolar or interstitial macrophages, which accumulate in the connective tissue. On prolonged exposure, lung tissue undergoes&nbsp;<strong>progressive massive fibrosis,&nbsp;</strong>which is called complicated coal workers' pneumoconiosis.&nbsp;The&nbsp;<strong>upper lobes</strong>&nbsp;of the lungs are commonly involved.</p>\n<p>Microscopic features consist of&nbsp;<strong>coal-laden macrophages,&nbsp;</strong>black pigment, and dense collagenous interstitial fibrosis.&nbsp;</p>\n<p>The image below shows&nbsp;<strong>anthracosis</strong>&mdash;black pigment engulfed within macrophages as well as in the form of deposits.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e575a4b05e654058961f725d9da6fa51x1280x859.JPEG\" alt=\"Explanation Image\"><p>Option C:&nbsp;<strong>Silicosis&nbsp;</strong>is due to the inhalation of crystalline silicon dioxide (silica) as seen in individuals employed in <strong>sandblasting</strong> or rock mining. Macrophages phagocytose inhaled silica particles, thereby activating and releasing inflammatory mediators, like IL-1 and IL-8.</p>\n<p>Histopathology reveals coalescent <strong>nodules </strong>of <strong>whorled collagen fibers</strong> surrounded by a peripheral zone of dust-laden macrophages. Radiologically,&nbsp;<strong>egg-shell calcification</strong> of the lymph nodes is seen.</p>\n<p>Shown below is an image of a silicotic <strong>nodule with collagen whorls</strong> as seen in this condition.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/db43e6d9b088403b8e7dc0b754c8722cx1279x856.JPEG\" alt=\"Explanation Image\"><p>Option D:&nbsp;Bagassosis is an&nbsp;<strong>occupational lung disease</strong>&nbsp;caused by the inhalation of&nbsp;<strong>bagasse</strong>&nbsp;or sugarcane dust. A thermophilic actinomycete,&nbsp;<em><strong>Thermoactinomyces sacchari</strong></em>&nbsp;is the causative organism/ The symptoms are breathlessness, cough,&nbsp;<strong>hemoptysis</strong>, and&nbsp;<strong>fever</strong>. Initially, it can result in&nbsp;<strong>acute diffuse bronchiolitis</strong>. If left untreated it can progress to&nbsp;<strong>diffuse fibrosis</strong>, emphysema, and bronchiectasis.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/97acf1d1ac0641f0ae97bcfae7043b9c.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9963",
      "difficulty": "medium"
    },
    {
      "text": "A 20-year-old woman presents with complaints of yellowish discoloration of the skin for 1 week and severe fatigue. On examination, you notice her to have tachycardia, pallor, icterus, and splenomegaly. Her investigation reports are shown below. What is the underlying mechanism for this presentation?\n<div class='question-desc-html'><p>Serum hemoglobin- 6g/dL<br />Coomb’s test- positive<br />Serum LDH - elevated</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Type I hypersensitivity reaction"
        },
        {
          "id": 2,
          "text": "Type II hypersensitivity reaction"
        },
        {
          "id": 3,
          "text": "Type III hypersensitivity reaction"
        },
        {
          "id": 4,
          "text": "Type IV hypersensitivity reaction"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical presentation indicates hemolysis and a<strong> positive Coomb's test</strong> suggests <strong>autoimmune hemolytic anemia.</strong> The underlying mechanism of this condition is <strong>type II hypersensitivity reaction.</strong></p>\n<p>Since in autoimmune hemolytic anemia, antibodies recognize red cells and cause their premature destruction via<strong> opsonization</strong>, it is a type II hypersensitivity reaction.</p>\n<p>Elevated LDH indicates hemolysis and a positive Coomb's test is indicative of autoimmune hemolytic anemia. The presentation is usually dramatic with abrupt onset anemia, jaundice, and splenomegaly.</p><hr><h3>Related Pearl: Types of Type II Antibody-Mediated Hypersentivity</h3><p>There are 3 mechanisms involved in type 2 hypersensitivity reactions-&nbsp;</p>\n<ol>\n<li>Antibody-mediated <strong>cellular dysfunction-</strong>&nbsp;<strong>antibodies</strong>&nbsp;react with antigens present on <strong>cell surfaces</strong> or in the <strong>extracellular matrix</strong> cause disease by <strong>destroying</strong> these <strong>cells,</strong> triggering <strong>inflammation,</strong> or interfering with normal functions<br />\n<ol>\n<li>Myasthenia gravis (against acetylcholine receptor)</li>\n<li>Graves&rsquo; disease (against TSH receptor)</li>\n<li>Pemphigus Vulgaris (against epidermal cadherin)</li>\n<li>Pernicious anemia (against intrinsic factor)</li>\n<li>Insulin resistant diabetes (against insulin receptor</li>\n</ol>\n</li>\n<li>Antibody-mediated <strong>opsonization</strong> and <strong>phagocytosis</strong> -<strong>antibodies</strong> may deposit in <strong>tissues</strong> or <strong>blood vessels,</strong> and elicit an acute <strong>inflammatory</strong> reaction by activating <strong>complement</strong>&nbsp;and<strong> Recruiting Phagocytes</strong>\n<ol>\n<li>Transfusion reactions</li>\n<li>Erythroblastosis fetalis</li>\n<li>Autoimmune hemolytic anemia</li>\n<li>Autoimmune thrombocytopenic purpura</li>\n</ol>\n</li>\n<li><strong>Complement</strong> and <strong>Fc receptor-mediated inflammation-</strong>&nbsp;<strong>antibodies</strong>&nbsp;may deposit in&nbsp;<strong>tissues</strong>&nbsp;or&nbsp;<strong>blood vessels,</strong>&nbsp;and elicit an acute&nbsp;<strong>inflammatory</strong>&nbsp;reaction by activating&nbsp;<strong>complement</strong>\n<ol>\n<li>Goodpasture syndrome</li>\n<li>Vasculitis due to ANCA</li>\n<li>Acute rheumatic fever</li>\n<li>Vascular rejection in organ graft&nbsp;</li>\n</ol>\n</li>\n</ol><hr><h3>Related Pearl: Mechanisms of Hypersensitivity Reactions</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type</strong></p>\n</td>\n<td>\n<p><strong>Immune Mechanisms</strong></p>\n</td>\n<td>\n<p><strong>Histopathological lesions</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Immediate </strong><br /><strong>&nbsp;hypersensitivity<br />(type I)<br /></strong></p>\n<ul>\n<li>Anaphylaxis</li>\n<li>Allergies</li>\n<li>Bronchial asthma</li>\n<li>Atopic dermatitis</li>\n</ul>\n</td>\n<td>\n<p>Production of IgE antibody &rarr;immediate release of vasoactive amines from mast cells</p>\n</td>\n<td>\n<p>Vascular dilatation, edema, smooth muscle contraction, mucus production, tissue injury, inflammation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Antibody-mediated hypersensitivity<br />(type II)<br /></strong></p>\n<ul>\n<li>Autoimmune hemolytic anemia</li>\n<li>Goodpasture syndrome</li>\n</ul>\n</td>\n<td>\n<p>Production of IgG, IgM &rarr; binds to antigen on target cell or tissue &rarr; phagocytosis or lysis of target cell by activated complement or Fc receptors; recruitment of leukocytes</p>\n</td>\n<td>\n<p>Phagocytosis and lysis of cells; inflammation;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Immune complex-mediated hypersensitivity<br /> (type III)<br /></strong></p>\n<ul>\n<li>SLE</li>\n<li>Serum sickness</li>\n<li>Arthus reaction</li>\n</ul>\n</td>\n<td>\n<p>Deposition of antigen-antibody complexes &rarr; complement activation &rarr;recruitment of leukocytes by complement products and Fc receptors &rarr; release of enzymes and other toxic molecules</p>\n</td>\n<td>\n<p>Inflammation, necrotizing vasculitis (fibrinoid necrosis)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cell-mediated hypersensitivity<br />(type IV)</strong></p>\n<ul>\n<li>Contact dermatitis</li>\n<li>Multiple sclerosis</li>\n<li>Type 1 diabetes</li>\n<li>Tuberculosis</li>\n</ul>\n</td>\n<td>\n<p>Activated T lymphocytes &rarr;</p>\n<p>1. Release of cytokines, inflammation, and macrophage activation</p>\n<p>2. T-cell-mediated cytotoxicity</p>\n</td>\n<td>\n<p>Perivascular cellular infiltrates; edema; granuloma formation; cell destruction</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f55cab6c8fd44a7abfe8a663dde3980ex1280x2567.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b2a98b94d6a9479b8e6e885ee59366cex1280x2089.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d92e092ef5874477a6da091ca3b1234ax1280x1360.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/56fc1dfb49434818b5057534a97d6621x1280x4218.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG7734",
      "difficulty": "easy"
    },
    {
      "text": "An elderly man presented with language deficits, loss of mathematical skills and motor skills. His family reports that his symptoms began many years ago with forgetfulness and memory disturbances. He is now apathetic, withdrawn, agitated, and is prone to wandering. Which of the following is not seen in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Cortical atrophy"
        },
        {
          "id": 2,
          "text": "Spongiform cerebral cortex"
        },
        {
          "id": 3,
          "text": "Neurofibrillary tangles"
        },
        {
          "id": 4,
          "text": "Aβ amyloid deposition"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical scenario of an elderly male with <strong>forgetfulness</strong>, <strong>memory</strong> disturbances, <strong>language</strong> deficits, loss of&nbsp;<strong>mathematical</strong> skills and <strong>motor</strong> skills, apathy, withdrawal, agitation, and <strong>wandering</strong> is likely to have <strong>Alzheimer's disease</strong>. Spongiform transformation of the cerebral cortex is seen in Creutzfeldt-Jakob disease.&nbsp;</p>\n<p>Alzheimer's disease is the <strong>most common</strong> cause of <strong>dementia</strong> in the <strong>elderly</strong>. Its incidence increases with age. It has an <strong>insidious</strong> onset with deficits developing over the course of 5-10 years. Initially, the patient presents with <strong>forgetfulness</strong> but then progresses to language deficits, loss of&nbsp;mathematical skills, and motor skills. In the end stages, the patient becomes mute, incontinent, unable to walk. They usually develop <strong>pneumonia</strong>.&nbsp;</p>\n<p>The pathogenesis of Alzheimer's disease involves the accumulation of&nbsp;<strong>A&beta; amyloid </strong>and<strong> tau</strong> in the brain. The hallmarks of this condition are <strong>amyloid plaques</strong> comprised of aggregated&nbsp;A&beta; amyloid and <strong>neurofibrillary tangles</strong>. Neurofibrillary <strong>tangles</strong> are the <strong>cytoplasmic</strong> accumulation of <strong>tau</strong> filaments. Neuritic plaques are focal collections of axonal or dendritic processes around a central <strong>amyloid core</strong>. In pyramidal neurons, they appear as <strong>flame-shaped</strong>. These lesions lead to <strong>neuronal</strong> death.&nbsp;</p>\n<p>On gross examination, the brain shows <strong>cortical atrophy</strong> which can be seen with gyral narrowing and sulcal widening in the frontal, temporal, and parietal lobes. This will lead to compensatory enlargement of the ventricles.&nbsp;</p>\n<p>The following image shows the neurofibrillary tangles seen in Alzheimer's disease.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e2431742a8824843ab5f60507f46da33x1280x945.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Synucleinopathies and tauopathies</h3><div dir=\"ltr\"><span><strong>Synucleinopathies:</strong></span></div>\n<ul>\n<li dir=\"ltr\"><span>Parkinson&rsquo;s disease</span></li>\n<li dir=\"ltr\"><span>Dementia with Lewy bodies</span></li>\n<li dir=\"ltr\"><span>Multiple system atrophy</span></li>\n<li dir=\"ltr\"><span>REM behavioral disorder</span></li>\n<li dir=\"ltr\"><span>Pure autonomic failure</span>&nbsp;</li>\n</ul>\n<div dir=\"ltr\"><span><strong>Tauopathies:</strong></span></div>\n<ul>\n<li dir=\"ltr\"><span>Alzheimer&rsquo;s disease</span></li>\n<li dir=\"ltr\"><span>Down syndrome</span></li>\n<li dir=\"ltr\"><span>Progressive supranuclear palsy</span></li>\n<li dir=\"ltr\"><span>Corticobasal degeneration</span></li>\n<li dir=\"ltr\"><span>Pick&rsquo;s disease/frontotemporal dementia</span></li>\n<li dir=\"ltr\"><span>Chronic traumatic encephalopathy/punch drunk syndrome/dementia pugilistica</span></li>\n<li dir=\"ltr\"><span>Postencephalitic parkinsonism</span></li>\n<li dir=\"ltr\"><span>Pantothenate kinase-associated degeneration</span></li>\n<li dir=\"ltr\"><span>Niemann Pick disease type C</span></li>\n<li dir=\"ltr\"><span>Subacute sclerosing panencephalitis</span></li>\n</ul><hr><h3>Related Pearl: Differential diagnosis of dementia</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Condition</strong></span></td>\n<td><span><strong>Features</strong></span></td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Alzheimer&rsquo;s disease</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Insidious onset</span></li>\n<li><strong><span>Short-term memory loss</span></strong></li>\n<li><span>Language deficits and spatial disorientation</span></li>\n<li><span>Later, personality changes</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Vascular Dementia</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Stepwise decline</span></li>\n<li><strong><span>Early executive dysfunction</span></strong></li>\n<li><span>Cerebral infarction &amp;/or deep white matter changes on neuroimaging</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Frontotemporal dementia</strong></span></div>\n<div><span><strong>(Pick&rsquo;s disease)</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Early <strong>personality changes</strong></span></li>\n<li><span>Apathy, disinhibition &amp; compulsive behaviors</span></li>\n<li><span>Frontotemporal atrophy on neuroimaging</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Dementia with Lewy bodies</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span><strong>Visual Hallucination</strong></span></li>\n<li><span>Spontaneous parkinsonism</span></li>\n<li><span>Fluctuating cognition</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Normal-pressure hydrocephalus</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Gait abnormalities&nbsp;</span></li>\n<li><span>Urinary Incontinence</span></li>\n<li><span>Dementia</span></li>\n<li><strong><span>Dilated ventricles on neuroimaging</span></strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Creutzfeldt-Jakob disease</strong></span></div>\n<div><span><strong>(Prion disease)</strong></span></div>\n</td>\n<td>\n<ul>\n<li><strong><span>Behavioral changes</span></strong></li>\n<li><span>Rapidly progressive</span></li>\n<li><span>Myoclonus and/or seizures</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF3943",
      "difficulty": "easy"
    },
    {
      "text": "A 58-year-old woman, previously diagnosed with breast cancer, is now found to have endometrial cancer. Genetic testing revealed a mutation in the PTEN gene. What other condition is she at increased risk of developing?",
      "choices": [
        {
          "id": 1,
          "text": "Hepatocellular carcinoma"
        },
        {
          "id": 2,
          "text": "Ovarian carcinoma"
        },
        {
          "id": 3,
          "text": "Colorectal carcinoma"
        },
        {
          "id": 4,
          "text": "Thyroid carcinoma"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>A patient with a <strong>PTEN germline mutation</strong> with history of <strong>breast carcinoma</strong>, now diagnosed with <strong>endometrial carcinoma</strong> is at high risk of developing <strong>thyroid carcinoma </strong>concerning <strong>cowden syndrome.</strong></p>\n<p><strong>Cowden syndrome</strong> is an <strong>autosomal dominant</strong> disorder associated with<strong> pTEN germline mutations</strong> and marked by:</p>\n<ul>\n<li><strong>Hamartomatous growths</strong> of the skin and mucus membranes- buccal, intestinal, and colonic</li>\n<li><strong>Increased incidence </strong>of<strong> epithelial cancers</strong> particularly of the <strong>breast</strong>, <strong>endometrium</strong>, and <strong>thyroid </strong></li>\n</ul><hr><h3>Related Pearl: Polyposis Syndromes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Hereditary</strong></p>\n</td>\n<td>\n<p><strong>Non-hereditary</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Familial adenomatous polyposis syndrome (FAPS)</p>\n<p>Classic FAP</p>\n<p>Attenuated FAP</p>\n<p>Gardner syndrome</p>\n<p>Turcot syndrome</p>\n</td>\n<td>\n<p>Serrated polyposis syndrome (SPS), also known as hyperplastic polyposis syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bannayan&ndash;Riley&ndash;Ruvalcaba syndrome</p>\n</td>\n<td>\n<p>Cronkhite- Canada syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cowden syndrome</p>\n</td>\n<td>\n<p>Juvenile polyposis syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Peutz-Jeghers syndrome</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Tuberous sclerosis</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Juvenile polyposis syndrome</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Familial renal cell carcinoma syndromes</h3><table>\n<tbody>\n<tr>\n<td><strong>Syndrome</strong></td>\n<td><strong>Mutation in&nbsp;</strong></td>\n<td><br /><strong>Clinical manifestations</strong></td>\n</tr>\n<tr>\n<td><strong>von Hippel&ndash;Lindau</strong></td>\n<td><em>VHL</em> gene (3p 25-26)</td>\n<td>\n<ul>\n<li aria-level=\"1\"><strong>Clear cell RCC</strong>, renal cysts</li>\n<li aria-level=\"1\">Retinal angiomas (benign)</li>\n<li aria-level=\"1\">CNS hemangioblastomas&nbsp;(benign)</li>\n<li aria-level=\"1\">Pheochromocytoma</li>\n<li aria-level=\"1\">Neuroendocrine tumors</li>\n<li aria-level=\"1\">Cystadenoma</li>\n<li aria-level=\"1\">Endolymphatic sac tumors</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Hereditary papillary RCC</strong></td>\n<td><em>C-met</em> proto-oncogene (7q31)</td>\n<td><br />\n<ul>\n<li aria-level=\"1\">Multiple &amp; bilateral type1 <strong>papillary RCC</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Tuberous sclerosis&nbsp;</strong></td>\n<td><em>TSC1 (9q34)&nbsp;TSC2 (16p13)</em></td>\n<td>\n<ul>\n<li><strong>Clear cell RCC</strong></li>\n<li>Multiple renal<strong> angiomyolipomas</strong></li>\n<li>Polycystic kidney disease</li>\n<li aria-level=\"1\">Cutaneous angiofibroma</li>\n<li>Periungual fibroma</li>\n<li aria-level=\"1\">Shagreen patch</li>\n<li aria-level=\"1\">Ashleaf macules</li>\n<li aria-level=\"1\">Cardiac Rhabdomyoma</li>\n<li aria-level=\"1\">Subependymal nodules</li>\n<li aria-level=\"1\">Cortical tubers in CNS</li>\n<li aria-level=\"1\">Pulmonary lymphangiomyomatosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Birt&ndash;Hogg&ndash;Dube&nbsp;</strong></td>\n<td><em>BHD</em> gene: Folliculin (17p11)</td>\n<td>\n<ul>\n<li aria-level=\"1\">Multiple <strong>chromophobe RCC</strong></li>\n<li aria-level=\"1\">Hybrid oncocytic tumor&nbsp;</li>\n<li aria-level=\"1\">Oncocytomas&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>\n<li aria-level=\"1\"><strong>Clear-cell RCC&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></li>\n<li aria-level=\"1\"><strong>Papillary RCC&nbsp;</strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>\n<li aria-level=\"1\">Facial fibrofoliculomas&nbsp;&nbsp;&nbsp;</li>\n<li aria-level=\"1\">Lung cysts&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>\n<li aria-level=\"1\">Spontaneous pneumothorax</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Hereditary leiomyomatosis</strong></td>\n<td><em>Fumarate hydratase</em> (1q42-43)</td>\n<td>\n<ul>\n<li aria-level=\"1\"><strong>Type 2 papillary RCC&nbsp;&nbsp;&nbsp;</strong></li>\n<li aria-level=\"1\"><strong>Collecting-duct RCC&nbsp;</strong></li>\n<li aria-level=\"1\">Leiomyomas of skin or uterus</li>\n<li aria-level=\"1\">Uterine leiomyosarcomas</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Cowden syndrome</strong></td>\n<td><em>PTEN</em> (10q23)&nbsp;</td>\n<td>\n<ul>\n<li aria-level=\"1\">Benign and malignant breast tumors&nbsp;</li>\n<li aria-level=\"1\">Epithelial thyroid carcinoma</li>\n<li aria-level=\"1\"><strong>Papillary RCC</strong> or other histological subtypes</li>\n</ul>\n&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note: RCC with syndromic associations tends to be bilateral. They also occur early in life.</p>\n<p><em>VHL</em>: von Hippel&ndash;Lindau</p>\n<p>RCC: Renal cell carcinoma</p>\n<p><em>PTEN</em>: phosphatase and tensin homolog gene</p>\n<p><em>BHD</em>: Birt Hogg Dube</p>\n<p><em>TSC</em>:&nbsp;Tuberous sclerosis complex</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC8574",
      "difficulty": "medium"
    },
    {
      "text": "A 32-year-old woman presents with lower abdominal pain, which is worse during menstruation. Laparoscopic examination of the pelvis demonstrates multiple small brown spots on the surface of pelvic structures and extensive fibrous adhesions between tubes, ovaries, and other structures. A biopsy is done and microscopy is as shown below. Which of the following is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Adenomyosis"
        },
        {
          "id": 2,
          "text": "Chronic endometritis"
        },
        {
          "id": 3,
          "text": "Endometriosis"
        },
        {
          "id": 4,
          "text": "Metastatic endometrial cancer"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Microscopy shows <strong>glands resembling endometrial glands surrounded by endometrial stroma</strong> in the ovary. The most likely diagnosis is <strong>endometriosis.</strong>&nbsp;</p>\n<p>Endometriosis is defined by the <strong>presence of ectopic endometrial tissue </strong>at a site <strong>outside of the uterus. </strong>Includes both endometrial glands and stroma, but may consist only of stroma in some cases<strong>.&nbsp;</strong></p>\n<p>It occurs in the following sites, in descending order of frequency</p>\n<ul>\n<li>Ovaries</li>\n<li>Uterine ligaments</li>\n<li>Rectovaginal septum</li>\n<li>Cul de sac</li>\n<li>Pelvic peritoneum</li>\n<li>Large and small bowel and appendix</li>\n<li>Mucosa of the cervix, vagina, and fallopian tubes</li>\n<li>Laparotomy scars.</li>\n</ul>\n<p>It is principally a disease of women in active reproductive life, most often in the third and fourth decades. It causes infertility, dysmenorrhea (painful menstruation), pelvic pain, and other problems.&nbsp;<strong>Endometriotic lesions bleed </strong>periodically in response to both extrinsic cyclic (ovarian) and intrinsic hormonal stimulation.</p>\n<p>The diagnosis is readily made when both endometrial glands and stroma are present with or without the presence of hemosiderin. In rare cases, only the stroma is identified.</p>\n<p><strong>Atypical endometriosis, </strong>the likely precursor to endometriosis-related ovarian carcinoma, has two morphologic appearances. One consists of cytologic atypia of the epithelium lining the endometriotic cyst without major architectural changes. The second is marked by glandular crowding due to excessive epithelial proliferation, often associated with cytologic atypia, producing an appearance that resembles complex atypical endometrial hyperplasia.</p>\n<p>Other options</p>\n<p>Option A- Adenomyosis is characterized by foci of the endometrium deep in the myometrium.</p>\n<p>Option B- Chronic endometritis is a chronic inflammation of the endometrium.</p>\n<p>Option C- Metastatic endometrial carcinoma would be characterized by abnormal glands and cytologic atypia.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/655afe45457542b09b39a9e7bd0679a4.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9386",
      "difficulty": "medium"
    },
    {
      "text": "A 25-year-old man developed nausea and jaundice over the past week. Laboratory investigations revealed an active hepatitis B infection. Which of the following liver pathology findings is depicted in the slide below?",
      "choices": [
        {
          "id": 1,
          "text": "Granuloma formation"
        },
        {
          "id": 2,
          "text": "Abscess formation"
        },
        {
          "id": 3,
          "text": "Coagulative necrosis"
        },
        {
          "id": 4,
          "text": "Apoptosis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The above histopathological image shows <strong>Councilman's bodies&nbsp;</strong>and they represent <strong>apoptosis</strong>.</p>\n<p>Councilman's bodies are <strong>acidophilic</strong> bodies, which represent hepatocytes undergoing apoptosis. They&nbsp;are mainly seen in <strong>acute viral hepatitis</strong>.</p>\n<p><strong>Apoptosis</strong> is a pathway of cell death that is induced by a closely regulated suicide program in which the cells destined to die activate intrinsic enzymes that degrade the cells' nuclear and cytoplasmic proteins.&nbsp;</p>\n<p><strong>Mechanism of apoptosis:&nbsp;</strong>There are two distinct pathways that can lead to caspase activation and cause apoptosis of the cell.</p>\n<ul>\n<li>The mitochondrial or intrinsic pathway</li>\n<li>The death receptor or extrinsic pathway</li>\n</ul>\n<p><strong>The mitochondrial (intrinsic) pathway of apoptosis:</strong></p>\n<ul>\n<li>There are several proteins in the mitochondria that can induce apoptosis. These include&nbsp;<strong>cytochrome c</strong>&nbsp;and some proteins that neutralize the endogenous inhibitors of apoptosis.</li>\n<li>The permeability of the mitochondria is controlled by a family of proteins called the BCL-2 family, which act as sensors.</li>\n<li>These sensors are activated when the cells are deprived of growth factors and other survival signals, are exposed to agents that damage the DNA, or accumulate a large number of misfolded proteins.</li>\n<li>These activated sensors,&nbsp;in turn, activate the&nbsp;<strong>proapoptotic molecules</strong>&nbsp;like&nbsp;<strong>BAX</strong>&nbsp;and&nbsp;<strong>BAK</strong>, which form channels in the mitochondrial membrane, through which cytochrome c and other mitochondrial proteins escape into the cytosol and cause activation of&nbsp;<strong>caspase-9</strong>, which, in turn, leads to the activation of the caspase cascade and, eventually, apoptosis of the cell.</li>\n<li>On the other hand, if all the growth factors and other survival signals are present, then they produce more&nbsp;<strong>antiapoptotic</strong>&nbsp;<strong>members</strong>&nbsp;of the BH1-4 family like the&nbsp;<strong>BCL2, MCL 1</strong>,&nbsp;and&nbsp;<strong>BCL</strong>-<strong>XL</strong>. These proteins limit the escape of proapoptotic mitochondrial proteins.</li>\n</ul>\n<p><strong>The death-receptor (extrinsic) pathway of apoptosis:</strong></p>\n<ul>\n<li>Death receptors are surface molecules that are members of the<strong>&nbsp;tumor necrosis factor (TNF) receptor family,</strong>&nbsp;like <strong>TNF 1</strong>&nbsp;and&nbsp;<strong>Fas (CD 95).</strong></li>\n<li>These receptors are expressed on the surface of many cells and can trigger apoptosis. In the cytoplasmic region, these receptors have a &ldquo;death domain.&rdquo;</li>\n<li><strong>Fas ligand (FasL)</strong>&nbsp;is a membrane protein expressed mainly on activated T-lymphocytes. Fas-FasL interactions are required for thymic medullary negative selection. Defective interactions also cause the autoimmune lymphoproliferative syndrome.&nbsp;</li>\n<li>When these T-cells recognize Fas-expressing targets, Fas molecules are cross-linked by FasL and bind adaptor proteins via the death domain.</li>\n<li>These,&nbsp;in turn, recruit and activate&nbsp;<strong>caspase-8 and -10</strong>.</li>\n<li>In many cell types, caspase-8 and -10 may cleave and activate a pro-apoptotic member of the Bcl-2 family called&nbsp;<strong>Bid</strong>, thus feeding into the mitochondrial pathway.</li>\n<li>The combined activation of both pathways delivers a lethal blow to the cell.</li>\n<li>Cellular proteins, notably, a caspase antagonist called&nbsp;<strong>FLIP</strong>, block the activation of caspases downstream of the death receptors. Interestingly, some viruses produce homologues of FLIP, and it is suggested that this is a mechanism that viruses use to keep infected cells alive.</li>\n<li>The death receptor pathway is involved in the&nbsp;elimination of self-reactive lymphocytes and in the killing of target cells by some cytotoxic T-lymphocytes.</li>\n</ul><hr><h3>Related Pearl: Pathological Named Bodies</h3><table>\n<tbody>\n<tr>\n<td><strong>Bodies</strong></td>\n<td><strong>Found in</strong></td>\n</tr>\n<tr>\n<td>Asteroid bodies</td>\n<td>Sarcoidosis, Sporotrichosis</td>\n</tr>\n<tr>\n<td>\n<p>Halberstaedter&ndash;Prowazek bodies</p>\n</td>\n<td>Trachoma&nbsp;</td>\n</tr>\n<tr>\n<td>Miyagawa bodies</td>\n<td>Lymphogranuloma venereum&nbsp;</td>\n</tr>\n<tr>\n<td>Levinthal&ndash;Cole&ndash;Lillie bodies</td>\n<td>Psittacosis</td>\n</tr>\n<tr>\n<td>Leishman&ndash;Donovan bodies</td>\n<td>Kala-azar&nbsp;</td>\n</tr>\n<tr>\n<td>Negri bodies</td>\n<td>Rabies</td>\n</tr>\n<tr>\n<td>Guarnieri bodies</td>\n<td>Vaccinia</td>\n</tr>\n<tr>\n<td>Bollinger bodies</td>\n<td>Fowl pox</td>\n</tr>\n<tr>\n<td>Henderson&ndash;Paterson bodies</td>\n<td>Molluscum contagiosum&nbsp;</td>\n</tr>\n<tr>\n<td>Cowdry type-A bodies</td>\n<td>Yellow fever, Herpes virus infection&nbsp;</td>\n</tr>\n<tr>\n<td>Cowdry type-B bodies</td>\n<td>Adenovirus, poliovirus</td>\n</tr>\n<tr>\n<td>Rusell bodies</td>\n<td>Multiple myeloma&nbsp;</td>\n</tr>\n<tr>\n<td>Aschoff bodies</td>\n<td>Rheumatic fever&nbsp;</td>\n</tr>\n<tr>\n<td>Call&ndash;Exner bodies</td>\n<td>Granulosa cell tumor of the&nbsp;ovary&nbsp;</td>\n</tr>\n<tr>\n<td>Civatte (colloid) bodies</td>\n<td>Lichen planus&nbsp;</td>\n</tr>\n<tr>\n<td>Michaelis&ndash;Gutmann bodies</td>\n<td>Malakoplakia&nbsp;</td>\n</tr>\n<tr>\n<td>Lewy bodies</td>\n<td>Parkinson's disease&nbsp;</td>\n</tr>\n<tr>\n<td>Pappenheimer bodies</td>\n<td>Non-heme iron pigments in siderocytes&nbsp;</td>\n</tr>\n<tr>\n<td>Howell&ndash;Jolly bodies</td>\n<td>Splenectomy, Megaloblastic Anemia, Hemolytic anemia&nbsp;</td>\n</tr>\n<tr>\n<td>Heinz bodies</td>\n<td>G-6-PD deficiency&nbsp;</td>\n</tr>\n<tr>\n<td>Gamna&ndash;Gandy bodies</td>\n<td>Congestive splenomegaly&nbsp;</td>\n</tr>\n<tr>\n<td>Mallory bodies</td>\n<td>Hyaline inclusions in hepatocytes seen in alcoholic cirrhosis, Indian childhood cirrhosis</td>\n</tr>\n<tr>\n<td>Councilman bodies</td>\n<td>Hepatocytes undergoing apoptosis,&nbsp;seen mainly in acute viral hepatitis.</td>\n</tr>\n<tr>\n<td>Psammoma bodies</td>\n<td>Dystrophic calcification in meningioma, papillary serous cystadenoma of ovary &amp; papillary carcinoma of thyroid, papillary type of renal cell carcinoma.</td>\n</tr>\n<tr>\n<td>Donovan bodies</td>\n<td>Granuloma inguinale&nbsp;</td>\n</tr>\n<tr>\n<td>Nissl's bodies</td>\n<td>Cytoplasmic inclusions in neurons&nbsp;</td>\n</tr>\n<tr>\n<td>Mooser bodies</td>\n<td>Typhus fever</td>\n</tr>\n<tr>\n<td>Creola bodies</td>\n<td>Asthma&nbsp;</td>\n</tr>\n<tr>\n<td>Verocay bodies</td>\n<td>Schwannoma&nbsp;</td>\n</tr>\n<tr>\n<td>Schiller&ndash;Duval bodies</td>\n<td>Endodermal sinus tumor&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Hirano bodies</p>\n</td>\n<td>&nbsp;Alzheimer&rsquo;s disease</td>\n</tr>\n<tr>\n<td>\n<p>Ferruginous bodies</p>\n</td>\n<td>Asbestosis&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Apoptotic genes</h3><table>\n<tbody>\n<tr>\n<td>Group</td>\n<td>Members</td>\n<td>Details</td>\n</tr>\n<tr>\n<td>Anti-apoptotlc</td>\n<td>BCL2,<br />BCL-XL<br /><br />MCL1</td>\n<td>Present in outer mitochondrial&nbsp;membrane<br />Prevent leakage of cytochrome-c and<br />other death lnducing proteins into<br />cytosol.</td>\n</tr>\n<tr>\n<td>Pro-apoptotlc</td>\n<td>BAX,<br />BAK</td>\n<td>On activation, they increase&nbsp;mitochondrial membrane permeability.</td>\n</tr>\n<tr>\n<td>Stress Sensors</td>\n<td>BAD,<br />BIM,<br />BID,<br />Puma, Noxa</td>\n<td>Act as sensors of cellular stress and&nbsp;damage and regulate the balance<br />between the other two groups</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Necrosis vs Apoptosis</h3><div class=\"page\" title=\"Page 51\">\n<table><colgroup><col /><col /><col /></colgroup>\n<tbody>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Feature</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Necrosis</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Apoptosis</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Mechanism</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Enzymatic or ischemic process</p>\n<p>Passive process</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Genetically programmed cell death</p>\n<p>Active process</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>Physiologic or pathologic role</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Invariably <strong>pathologic</strong>&nbsp;</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Both physiologic and pathologic</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Cell size</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Enlarged (swelling)</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Reduced (<strong>shrinkage</strong>)</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Cells affected</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Group of cells</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Single cell death</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Nucleus</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Pyknosis &rarr;karyorrhexis &rarr;karyolysis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Fragmentation into nucleosome-size fragments</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Plasma membrane</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Disrupted</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Intact</strong>; altered structure</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Cellular contents</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Enzymatic digestion; may leak out of cell</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Intact</strong>; may be released in apoptotic bodies</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Inflammation</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Present</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Absent</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Marker</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>No marker</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Annexin V</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>PAGE (DNA electrophoresis)</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Smear pattern</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Step-ladder pattern</strong></p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f78b37c3b38f4a478226c6278b94a572.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6404",
      "difficulty": "medium"
    },
    {
      "text": "A 30-year-old lady presents with fever, oral ulcers, photosensitivity, and a rash on her face, as seen below. Anti-dsDNA and anti-Smith antibodies are positive. Which of the following is deficient in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "C1 inhibitor"
        },
        {
          "id": 2,
          "text": "C1, C2, C4"
        },
        {
          "id": 3,
          "text": "C5 to C8"
        },
        {
          "id": 4,
          "text": "C3b and its regulatory protein"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The diagnosis based on the given clinical scenario and image is <strong>systemic lupus erythematosus </strong>(SLE).&nbsp;<strong>C1, C2,</strong>&nbsp;and<strong>&nbsp;C4&nbsp;</strong>complements are&nbsp;deficient in SLE patients.</p>\n<p>The rash seen in the image is a <strong>malar rash</strong> (classically seen in SLE); it is characterized by a well-demarcated erythematous butterfly rash over the malar eminences, with <strong>sparing of the nasolabial folds</strong>.&nbsp;Anti-dsDNA and anti-Smith antibodies are specific for SLE.</p>\n<p>Clinical syndromes associated with genetic deficiencies of various complement components:</p>\n<ul>\n<li><strong>C1 inhibitor deficiency</strong> - <strong>Hereditary angioedema</strong></li>\n<li><strong>C1, C2, C4 deficiency</strong> - <strong>SLE</strong> and other collagen vascular disorders</li>\n<li>C5-C8 deficiency - Toxoplasmosis, bacteremia with gram-negative diplococci&nbsp;</li>\n<li>C3 and its regulatory protein or C3b inactivator&nbsp;deficiency&nbsp;-&nbsp;Severe recurrent pyogenic infections</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f34a191781aa400d9231df99faf71b2a.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3538",
      "difficulty": "medium"
    },
    {
      "text": "You perform an autopsy of a 25-year-old male who suffered a sudden cardiac death and notice the chambers of the heart to be enlarged. You suspect the cause of death to be dilated cardiomyopathy. What can be a likely cause of this condition?\n<div class='question-desc-html'><p>i)Titin mutation</p>\n<p>ii)Dystrophin mutation</p>\n<p>iii)Myosin binding protein C mutation</p>\n<p>iv)Hemochromatosis</p>\n<p>v)Alcohol intake</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "i, iii, iv and v"
        },
        {
          "id": 2,
          "text": "i and v "
        },
        {
          "id": 3,
          "text": "i, ii , iv and v"
        },
        {
          "id": 4,
          "text": "i, ii , iii and iv"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Titin mutation</strong>, <strong>dystrophin mutation</strong>, <strong>hemochromatosis</strong> and <strong>alcohol intoxication</strong> can all lead to the development of <strong>dilated cardiomyopathy</strong> and thus are a likely cause of this condition- option (c) is the correct answer.</p>\n<p>Mutation of myosin binding protein C is the most common cause of hypertrophic cardiomyopathy not dilated cardiomyopathy thus is not a likely cause of this condition. </p>\n<p><strong>Causes of Dilated cardiomyopathy</strong></p>\n<ol>\n<li>\n<ol>\n<li>Familial (50%)- mutation of genes encoding proteins of cytoskeleton, sarcolemma and nuclear envelope<br />\n<ol>\n<li>TTN gene mutation encoding titin protein</li>\n<li>Dystrophin gene mutation - associated with skeletal myopathies ( Duchenne muscular dystrophy etc)</li>\n</ol>\n</li>\n<li>Alcohol intake<br />\n<ol>\n<li>Ethanol toxicity</li>\n<li>Chronic intake -&gt; thiamine deficiency -&gt; beriberi heart disease ( dilated cardiomyopathy)</li>\n</ol>\n</li>\n<li>Iron overload<br />\n<ol>\n<li>Hemochromatosis</li>\n<li>Multiple blood transfusions</li>\n</ol>\n</li>\n<li>Viral myocarditis</li>\n<li>Peripartum cardiomyopathy</li>\n<li>Cobalt toxicity</li>\n</ol>\n</li>\n</ol>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG7726",
      "difficulty": "medium"
    },
    {
      "text": "An 82-year-old male patient dies of severe congestive heart failure. An autopsy was done, which revealed the following appearance of the aortic valve. Blood investigations done before death revealed normal levels of serum sodium, potassium, calcium, and chloride. Which of the following pathological processes is likely to have resulted in the appearance of the aortic valve as shown in the image?",
      "choices": [
        {
          "id": 1,
          "text": "Amyloidosis"
        },
        {
          "id": 2,
          "text": "Monckeberg medial sclerosis"
        },
        {
          "id": 3,
          "text": "Dystrophic calcification"
        },
        {
          "id": 4,
          "text": "Metastatic calcification"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The image shows extensive <strong>calcification </strong>of the <strong>aortic valve</strong> resulting in stenosis. Calcification of the valve, in an elderly patient, with <strong>normal serum calcium levels,</strong>&nbsp;occurs due to <strong>dystrophic</strong> <strong>calcification</strong>.</p>\n<p>When the deposition of calcium occurs in dead or dying tissues, it is called&nbsp;<strong>dystrophic calcification</strong>. This occurs in the absence of derangements in calcium metabolism, i.e. the calcium levels are <strong>normal</strong>. Dystrophic calcification is seen in areas of necrosis of any type including coagulative, caseous, or liquefactive, and in foci of enzymatic fat necrosis.</p>\n<p>Some examples include <strong>atheromas</strong> of advanced atherosclerosis and areas of caseous necrosis in <strong>tuberculosis.</strong> It also commonly develops in <strong>aging</strong> or <strong>damaged heart valves.</strong></p>\n<p>Other options:</p>\n<p>Option A - <strong>Cardiac amyloidosis</strong> may occur secondary to systemic amyloidosis or as a result of aging (senile amyloidosis). It is associated with the deposition of hyaline, eosinophilic amyloid, in the conduction tissue, interstitium, and coronary vessels. These deposits may be seen on <strong>Congo red</strong> staining.</p>\n<p>Option B -&nbsp;<strong>Monckeberg medial sclerosis&nbsp;</strong>is a vascular pathology of aging characterized by&nbsp;<strong>calcifications</strong>&nbsp;accumulating in the medial layers of muscular arteries. Since there is no vascular compromise (no luminal narrowing), it is usually an accidental finding.</p>\n<p>Option D -<strong> Metastatic calcification</strong> occurs in normal tissues, in the presence of <strong>hypercalcemia.&nbsp;</strong>It is usually a consequence of excessive parathyroid hormone.</p><hr><h3>Related Pearl: Types of calcifications</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Dystrophic calcification</strong></td>\n<td><strong>Metastatic calcification</strong></td>\n</tr>\n<tr>\n<td>Location</td>\n<td>Dead and dying tissues</td>\n<td>Normal interstitial tissues of the vasculature, kidneys, lungs, and gastric mucosa.</td>\n</tr>\n<tr>\n<td>Calcium metabolism</td>\n<td>Normal</td>\n<td>deranged causing hypercalcemia</td>\n</tr>\n<tr>\n<td>Examples</td>\n<td>\n<p>Calcific valvular stenosis</p>\n<p>Advanced Atheromatous plaque</p>\n<p>Monckeberg medial sclerosis</p>\n</td>\n<td>\n<p>Parathyroid tumors</p>\n<p>Hypercalcemia of malignancy</p>\n<p>Paget disease</p>\n<p>vitamin D intoxication</p>\n<p>Sarcoidosis</p>\n<p>Renal failure</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/d7cab5e29dd0483e976ab090a144bb03.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7072",
      "difficulty": "easy"
    },
    {
      "text": "A 30-year-old male patient presents with a chronic history of heartburn. An upper GI endoscopy was done, and a biopsy from a suspicious lesion showed the following picture. Identify the condition and the special stain used to confirm the diagnosis.",
      "choices": [
        {
          "id": 1,
          "text": "H. pylori infection, silver stain"
        },
        {
          "id": 2,
          "text": "Adenocarcinoma esophagus, mucin stain"
        },
        {
          "id": 3,
          "text": "Barrett's esophagus, mucin stain"
        },
        {
          "id": 4,
          "text": "Squamous cell carcinoma, keratin stain"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The patient's symptoms and histology findings are suggestive of <strong>Barrett's esophagus</strong>, and <strong>mucin stain (Alcian blue) </strong>is used&nbsp;to identify <strong>goblet cells,</strong>&nbsp;which are indicative of the intestinal metaplasia occurring in the condition.</p>\n<div class=\"page\" title=\"Page 764\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Barrett's esophagus is a type of metaplasia at the gastro-esophagal junction due to chronic gastroesophageal reflux disease (GERD). The <strong>squamous</strong> esophageal mucosa is converted to a<strong> columnal/intestinal</strong> type that is better suited to handle acid reflux. It is associated with an increased risk of esophageal adenocarcinoma.</p>\n<p>Grossly it appears as tongues of red, velvety mucosa extending upward from the gastroesophageal junction. This metaplastic mucosa alternates with residual smooth, pale squamous (esophageal) mucosa. <strong>Goblet cells</strong> are diagnostic of Barrett's esophagus and have distinct mucous vacuoles that stain pale blue and impart the shape of a wine goblet to the remaining cytoplasm.</p>\n<p><strong>Alcian blue staining</strong> of&nbsp;<strong>mucin </strong>in&nbsp;Barrett's mucosa is shown in the image given below:</p>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/50b32812adb24f638f4cac6ad333de58x719x512.JPEG\" alt=\"Explanation Image\"><div class=\"page\" title=\"Page 764\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Other options:</p>\n</div>\n</div>\n</div>\n</div>\n<p><strong>Option A: <em>Helicobacter pylori</em> </strong>infection can be diagnosed with <strong>Warthin-Starry silver stain.&nbsp;</strong>It can also present with heartburn, but histology would show organisms within the surface mucus and inflammatory cell infiltrate below the epithelium in the <strong>antrum&nbsp;</strong>and not a columnar esophagus.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/af9bbb920d3d4141ba3fadbe0e9598d6x720x480.JPEG\" alt=\"Explanation Image\"><p>Option B: Barrett's esophagus and long-standing GERD can result in adenocarcinoma of distal esophagus. It would show increased intestinal-type glands with features of carcinoma.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b81da320fb45475d856ba92c85fd08e7x1280x853.JPEG\" alt=\"Explanation Image\"><p>Option D:&nbsp;Squamous cell carcinoma commonly occurs in the middle esophagus, and a well-differentiated tumor would show intercellular bridges and nests of keratin pearls.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6ec5656608464f739ec949ff551ae7acx1280x1131.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Various stains and their applications in Pathology and Microbiology</h3><table>\n<tbody>\n<tr>\n<td><strong>Staining technique</strong></td>\n<td><strong>Cells/inclusions stained</strong></td>\n<td><strong>Disorders</strong></td>\n</tr>\n<tr>\n<td><strong>H&amp;E</strong></td>\n<td>Most common stain used in routine&nbsp;<strong>histopathology</strong></td>\n<td>Commonly used for all slides</td>\n</tr>\n<tr>\n<td><strong>Papanicolaou stain</strong></td>\n<td>Universal stain for <strong>cytological</strong> preparations</td>\n<td>Cytological studies</td>\n</tr>\n<tr>\n<td><strong>PAS</strong></td>\n<td>Demonstrate&nbsp;<strong>glycogen,&nbsp;mucin,&nbsp;fungi, </strong>macrophages&nbsp;</td>\n<td>Whipple's disease, adenocarcinomas,&nbsp;and glycogen-positive tumors (Ewings sarcoma, renal cell carcinoma)</td>\n</tr>\n<tr>\n<td><strong><strong>PTAH (</strong></strong><strong>Phosphotungstic acid hematoxylin)</strong></td>\n<td>Fibrin</td>\n<td>Gliosis, Ependymomas, Tumours of skeletal muscles, Fibrin deposits</td>\n</tr>\n<tr>\n<td><strong>Alcian blue</strong></td>\n<td>For <strong>acid mucins</strong>: Positive stain for mucins of the intestinal mucosa and negative stain for mucins of gastric mucosa and Brunner's gland</td>\n<td>Barrett's esophagus, Gastric disorders</td>\n</tr>\n<tr>\n<td><strong>Perl's Prussian blue</strong></td>\n<td>Demonstrate&nbsp;<strong>hemosiderin and iron</strong></td>\n<td>Hemochromatosis&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Masson&ndash;Fontana stain</strong></td>\n<td>Demonstrate <strong>melanin</strong></td>\n<td>Nevus and malignant melanoma</td>\n</tr>\n<tr>\n<td><strong>von Kossa method</strong></td>\n<td>Demonstrate&nbsp;<strong>calcium</strong></td>\n<td>Calcification of tissues</td>\n</tr>\n<tr>\n<td><strong>Van Gieson stain</strong></td>\n<td>\n<p>Demonstrate <strong>collagen </strong>in; Differentiate amyloid from collagen</p>\n</td>\n<td>Spindle-cell neoplasm; Delineate extent of fibrosis&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Masson trichrome stain</strong></td>\n<td>Demonstrate <strong>collagen and muscle</strong></td>\n<td>Connective tissue disorders, muscle and fibroblast tumors, liver cirrhosis, neuromuscular diseases&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Reticulin stain</strong></td>\n<td>Demonstrate <strong>reticulin fibers</strong></td>\n<td>Distinguish epithelial from non-epithelial neoplasm, Hodgkin's lymphoma, early cirrhosis of the&nbsp;liver, myelofibrosis</td>\n</tr>\n<tr>\n<td><strong>Verhoeff's method</strong></td>\n<td>Demonstrate <strong>elastic fibers</strong></td>\n<td>Malignant hypertension, arteriovenous malformation aneurysms, Marfan's syndrome, emphysema lung</td>\n</tr>\n<tr>\n<td><strong>Oil red O</strong> <strong>Sudan Black</strong> <strong>Sudan III/IV</strong></td>\n<td>Demonstrate&nbsp;<strong>fat/lipids</strong></td>\n<td>Fatty liver-fat embolism-fibroma vs. thecoma of the&nbsp;ovary-liposarcoma&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Microbiology stains:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Stain</strong></td>\n<td><strong>&nbsp;Uses</strong></td>\n</tr>\n<tr>\n<td><strong>Ziehl&ndash;Neelsen Stain</strong></td>\n<td>Mycobacteria (all species, including <em>Mycobacterium leprae</em>), <em>Nocardia </em>spp. Cyst of&nbsp;<em>Cryptosporidium parvum</em>, <em>Isospora </em>spp., and&nbsp;<em>Cyclospora</em>&nbsp;spp., Head of sperms</td>\n</tr>\n<tr>\n<td><strong>Masson&rsquo;s Fontana</strong></td>\n<td>Melanin and argentaffin Cells</td>\n</tr>\n<tr>\n<td><strong>Gomori Methenamine Silver</strong></td>\n<td>Fungi</td>\n</tr>\n<tr>\n<td><strong>Luxol Fast Blue (LFB)</strong></td>\n<td>Myelin</td>\n</tr>\n<tr>\n<td><strong>Phosphotungstic Acid-hematoxylin</strong></td>\n<td>Cross striations of skeletal muscle, fibrin</td>\n</tr>\n<tr>\n<td><strong>Toluidine blue</strong></td>\n<td>Mast cells</td>\n</tr>\n<tr>\n<td><strong>Warthin&ndash;Starry</strong></td>\n<td>Helicobacter pylori, spirochetes</td>\n</tr>\n<tr>\n<td><strong>Van Gieson</strong></td>\n<td>Collagen fibres</td>\n</tr>\n<tr>\n<td><strong>Mucicarmine</strong></td>\n<td>Mucin, <em>Cryptococcus</em> capsule</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/990e7500202a4091b0aabd34e20defce.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7936",
      "difficulty": "easy"
    },
    {
      "text": "A 45-year-old man presents with oliguria, haematuria, and pedal edema over the past 3 days. He complains that his symptoms worsened rapidly. On examination, he has a BP of 190/140 mmHg. Blood workup shows elevated serum creatinine and blood urea. Histological studies show crescents in the glomeruli as seen in the image below. Which of the following type of nephritis does the clinical scenario suggest?",
      "choices": [
        {
          "id": 1,
          "text": "Rapidly progressive glomerulonephritis"
        },
        {
          "id": 2,
          "text": "Minimal change disease"
        },
        {
          "id": 3,
          "text": "Focal segmental glomerulosclerosis"
        },
        {
          "id": 4,
          "text": "Membranoproliferative glomerulonephritis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The rapidly worsening symptoms and the histologic picture are suggestive of <strong>rapidly progressive glomerulonephritis</strong>&nbsp;(RPGN) also known as <strong>crescentic glomerulonephritis</strong>.&nbsp;</p>\n<p>It is a syndrome associated with severe glomerular injury with necrosis and the formation of crescents. The&nbsp;disease progresses rapidly and leads to renal failure in weeks to months when not treated. In&nbsp;the majority of the cases, RPGN is&nbsp;immune-mediated.&nbsp;In pauci-immune type of RPGN, circulating&nbsp;<strong>anti-neutrophil cytoplasmic antibodies</strong> (ANCAs) are detected in most cases.&nbsp;Serum analyses for anti-GBM antibodies, antinuclear antibodies, and ANCAs are helpful in the diagnosis of specific subtypes.</p>\n<p>Other options:</p>\n<p>Option B:<strong>&nbsp;Minimal change disease</strong> - presence of difuse <strong>effacement </strong>of<strong> podocytes</strong> (epithelial cell foot process) which is characteristic. It is one of the common causes of <strong>nephrotic syndrome</strong>. However, this glomerular abnormality can only be detected using electron microscopy and appear normal by light microscopy.&nbsp;</p>\n<p>Option C:&nbsp;<strong>Focal segmental glomerulosclerosis</strong> - presence of <strong>focal </strong>and<strong> segmental scarring</strong> of the <strong>glomeruli</strong> most prominently seen at the corticomedullary junction.</p>\n<p>Option D:&nbsp;<strong>Membranoproliferative glomerulonephritis</strong> - presence of thickenend glomerular basement membrane with <strong>mesangioproliferation</strong> and are of three types where type 1 is associated with hepatitis C infection while type 2 and 3 are idiopathic or complement mediated.</p><hr><h3>Related Pearl: Types of Rapidly Progressive Glomerulonephritis</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type I (Anti-GBM Antibody)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Renal limited</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Goodpasture syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Immunofluorescence:&nbsp;</p>\n<p>Linear GBM deposits of IgG and C3</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Type II (Immune Complex)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Idiopathic</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Post-streptococcal glomerulonephritis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Membranoproliferative glomerulonephritis</p>\n</td>\n</tr>\n<tr>\n<td>Crescentic glomerulonephritis</td>\n</tr>\n<tr>\n<td>\n<p>Lupus nephritis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Henoch&ndash;Sch&ouml;nlein purpura</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IgA nephropathy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Others:&nbsp;Cryoglobulinemia,&nbsp;Bacterial endocarditis, sepsis,&nbsp;acute pancreatitis/advanced liver disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Immunofluorescence:&nbsp;Granular pattern of staining</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Type III (Pauci-Immune)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>ANCA-associated</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Idiopathic</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Granulomatosis with polyangiitis (formerly Wegener granulomatosis)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Microscopic polyangiitis</p>\n</td>\n</tr>\n<tr>\n<td>Immunofluorescence:&nbsp;No immunoglobulin or complement deposits</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>Image: Crescentic glomerulonephritis (PAS stain) with the crescent-shaped mass of proliferating parietal epithelial cells and leukocytes internal to Bowman capsule.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bc82f88b949d4f94bfd60049ae235674x800x533.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1da539adb07347789a398d272db0f337x1279x1112.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://upload.wikimedia.org/wikipedia/commons/6/69/Crescentic_glomerulonephritis_-_very_high_mag.jpg"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9537",
      "difficulty": "medium"
    },
    {
      "text": "The genetic testing of a 2-year-old boy presenting with an abdominal mass and other congenital anomalies revealed deletion of WT1 and PAX6 genes. Which of the following features is seen in this syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Warthin tumor"
        },
        {
          "id": 2,
          "text": "Retinal detachment"
        },
        {
          "id": 3,
          "text": "Gastrointestinal abnormalities"
        },
        {
          "id": 4,
          "text": "Intellectual disability"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>WT1 </strong>and<strong> PAX6 gene deletion</strong> results in <strong>WAGR syndrome</strong>. This syndrome leads to<strong> intellectual disability. </strong></p>\n<p>The components of<strong> WAGR syndrome </strong>are </p>\n<ul>\n<li>Wilms tumor</li>\n<li>Aniridia</li>\n<li>Genitourinary abnormalities</li>\n<li>Intellectual disability</li>\n</ul>\n<p><strong>PAX6 deletion</strong> alone increases the risk of developing <strong>aniridia</strong>, and <strong>WT1 deletion</strong> increases the risk of developing <strong>Wilms tumor</strong>. However, both of these genes are located on chromosome 11p13. Thus, deletion of 11p13 leads to the deletion of both genes, leading to the development of WAGR syndrome.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG7724",
      "difficulty": "hard"
    },
    {
      "text": "A 10-year-old boy presents with dark urine, fatigue and jaundice following the use of antimalarials. The peripheral blood smear shows cells as in the image below. All of the following findings can be seen in the patient except",
      "choices": [
        {
          "id": 1,
          "text": "Normocytic normochromic anemia"
        },
        {
          "id": 2,
          "text": "Elevated LDH"
        },
        {
          "id": 3,
          "text": " Absent haptoglobin "
        },
        {
          "id": 4,
          "text": "Positive direct Coomb’s test"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The patient’s peripheral blood smear shows <strong>bite cells </strong>characteristic of <strong>G6PD deficiency</strong>, likely precipitated after the use of <strong>antimalarials </strong>in this case.<strong> </strong>A<strong> positive direct Coomb’s </strong>test is unlikely in G6PD deficiency; it is seen in <strong>autoimmune hemolytic anemia</strong>.</p>\n<p>G6PD deficiency is an X-linked recessive disorder, in which the patient is usually asymptomatic unless challenged by oxidative agents such as fava beans, infections, and certain drugs leading to episodes of<strong> </strong>hemolytic anemia. </p>\n<p>Intravascular hemolysis in G6PD deficiency leads to <strong>normocytic normochromic anemia </strong>(causes fatigue)<strong>,</strong> hemoglobinemia, hemoglobinuria (causes dark-colored urine),<strong> elevated LDH, absent</strong>/<strong>low haptoglobin </strong>(options b, c, d).</p>\n<p>A blood smear may show<strong> Blister or bite cells </strong>and<strong> Heinz inclusion bodies</strong> (denatured hemoglobin within RBC):</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6542e1b161804bd68b962f9accf74317x1279x914.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ce8201ff8a0b460da85f0690ff4cc5d6x1279x914.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/785620d469ff4072a976291503d9518d.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG7692",
      "difficulty": "medium"
    },
    {
      "text": "A 62-year-old woman presents with a rapidly enlarging midline neck swelling, along with hoarseness of voice and dyspnea. The histopathological study of the biopsy is given below. What is the most likely cause?",
      "choices": [
        {
          "id": 1,
          "text": "Anaplastic thyroid carcinoma"
        },
        {
          "id": 2,
          "text": "Follicular thyroid carcinoma"
        },
        {
          "id": 3,
          "text": "Medullary thyroid carcinoma"
        },
        {
          "id": 4,
          "text": "Papillary thyroid carcinoma"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario and the histopathology slide showing <strong>sheets</strong> of<strong> undifferentiated, anaplastic cells</strong> with<strong> marked cytologic atypia,</strong> are likely suggestive of <strong>anaplastic thyroid carcinoma.</strong></p>\n<p>Anaplastic thyroid carcinoma is a rare and one of the <strong>most aggressive</strong> malignancies in humans. It is usually diagnosed in the <strong>elderly</strong> and there is a <strong>female</strong> preponderance. The clinical features include <strong>rapidly enlarging neck mass</strong>, <strong>dysphagia, hoarseness,</strong> cough, and hemoptysis. Patients have distant <strong>metastasis</strong> at the time of presentation and the most common sites include lungs, bone, and brain.</p>\n<p><strong>Management</strong>&nbsp;of anaplastic thyroid carcinoma (ATC) is as follows:</p>\n<ul>\n<li><strong>Total thyroidectomy</strong>&nbsp;with&nbsp;<strong>central node dissection</strong>&nbsp;is the recommended surgery.</li>\n<li><strong>En bloc resection</strong>- if an&nbsp;<strong>extrathyroidal extension</strong>&nbsp;is present.</li>\n<li>Postoperative external beam irradiation or&nbsp;<strong>adjunctive chemotherapy</strong>&nbsp;(adriamycin + paclitaxel/cisplatin) is given to prolong survival.</li>\n</ul><p>Other options:</p>\n<p>Option B:&nbsp;<strong>Follicular thyroid carcinoma</strong> shows uniform cells forming small follicles and they are filled with colloid and normal thyroid tissue. The below image shows follicular thyroid carcinoma.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/193489792df741fdb424aeae92c35ce1x1280x853.JPEG\" alt=\"Explanation Image\"><p>Option C: <strong>Medullary carcinoma</strong> has polygonal to spindle-shaped cells forming nests or trabeculae and contains <strong>amyloid</strong> deposits in the <strong>stroma.</strong> The below image shows medullary thyroid carcinoma.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7fcbabd939d34a1393e632024e677a43x1280x853.JPEG\" alt=\"Explanation Image\"><p>Option D: <strong>Papillary thyroid carcinoma</strong> is characterised by branching papillae, <strong>orphan Annie eye nuclei</strong>&nbsp;are nuclei with finely dispersed chromatin and <strong>psammoma bodies </strong>that&nbsp;are concentric calcified structures within the papillae. They are shown below in the image.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e80fc7a0625c47cf9cfb18e2907249eex720x542.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: AJCC 8th edition Changes in the TNM staging of Thyroid neoplasms:</h3><p><strong>Differentiated Thyroid Cancer:</strong></p>\n<ul>\n<li>The <strong>age</strong> <strong>cutoff</strong> used for staging is increased from 45 to <strong>55 years</strong> of age at diagnosis.&nbsp;</li>\n<li><strong>Minor extrathyroidal extension</strong> detected only on histological examination is <strong>removed from the definition of T3</strong> disease and therefore has no impact on either T category or overall stage.</li>\n<li>N1 disease no longer upstages a patient to stage III. If<strong> &lt; 55 years</strong> of age at diagnosis, <strong>N1 disease is stage I</strong>. If <strong>&ge; 55 years</strong> of age, <strong>N1 disease is stage II.</strong></li>\n<li><strong>T3a</strong> is a new category for tumors <strong>&gt; 4 cm confined to the thyroid gland</strong></li>\n<li><strong>T3b</strong> is a new category for tumors of any size demonstrating<strong> gross extrathyroidal extension into strap muscles</strong> (sternohyoid, sternothyroid, thyrohyoid or omohyoid muscles)</li>\n<li><strong>Level VII</strong> lymph nodes, previously classified as lateral neck lymph nodes (N1b) is re-classified as central neck lymph nodes <strong>(N1a)</strong> to be more anatomically consistent and because level VII presented significant coding difficulties for tumor registrars, clinicians and researchers.</li>\n<li>In differentiated thyroid cancer, the presence of <strong>distant metastases</strong> <strong>(M1)</strong> in older patients is classified as <strong>IVB</strong> disease rather than IVC disease. Distant metastasis in anaplastic thyroid cancer continues to be classified as IVC disease.</li>\n</ul>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>TNM staging</td>\n<td>7th AJCC (2010)</td>\n<td><strong>8th AJCC (2018)</strong></td>\n</tr>\n<tr>\n<td>Primary tumor(pT)</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>TX</td>\n<td>Cannot be assessed</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>T0</td>\n<td>No evidence of cancer</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>T1</td>\n<td>Tumor &le; 2 cm, intrathyroidal\n<ul>\n<li>T1a:&nbsp;&le;1 cm, intrathyroidal</li>\n<li>T1b<strong>:</strong>&nbsp;1-2 cm, intrathyroidal</li>\n</ul>\n</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>T2</td>\n<td>\n<div class=\"page\" title=\"Page 927\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>2-4 cm, intrathyroidal</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>T3</td>\n<td>\n<div class=\"page\" title=\"Page 927\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>&gt;4 cm limited to the thyroid or any size with minimal extrathyroidal extension (muscle, soft tissue)</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td><br />\n<ul>\n<li><strong>T3a:&nbsp;</strong>Tumor <strong>&gt;4 cm limited to the thyroid</strong></li>\n<li><strong>T3b:&nbsp;Gross extrathyroidal extension</strong> invading only <strong>strap muscles</strong> (sternohyoid, sternothyroid, thyrohyoid or omohyoid muscles) from a tumor of any size</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>T4</td>\n<td>\n<div class=\"page\" title=\"Page 927\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>T4a Invades subcutaneous tissue, larynx, trachea, esophagus, or RLN</li>\n<li>T4b Invades prevertebral fascia or encases carotid or mediastinal vessels</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>-do-<br /><br /></p>\n</td>\n</tr>\n<tr>\n<td>Regional lymph nodes (pN)</td>\n</tr>\n<tr>\n<td>NX</td>\n<td>Regional lymph nodes cannot be assessed</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>N0</td>\n<td>No lymph node metastasis</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>N1a</td>\n<td>\n<div class=\"page\" title=\"Page 927\">\n<div class=\"page\" title=\"Page 927\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Positive in level VI; unilateral or bilateral disease</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td><strong>Metastasis to level VI or VII;&nbsp;</strong>unilateral or bilateral disease</td>\n</tr>\n<tr>\n<td>N1b</td>\n<td>\n<div class=\"page\" title=\"Page 927\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Metastasis to unilateral, bilateral or contralateral lateral neck lymph nodes (levels I, II, III, IV or V) or retropharyngeal lymph nodes</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>-do-<br /><br /></td>\n</tr>\n<tr>\n<td>Distant metastasis (pM)</td>\n</tr>\n<tr>\n<td>M0</td>\n<td>No Distant metastasis</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>M1</td>\n<td>Distant metastasis present</td>\n<td>-do-</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><p><strong>TNM classification of thyroid tumors according to AJCC 7<sup>th</sup> edition vs 8<sup>th</sup> edition:</strong></p><table>\n<tbody>\n<tr>\n<td colspan=\"3\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; TNM CLASSIFICATION of Thyroid tumors</td>\n</tr>\n<tr>\n<td colspan=\"3\">PAPILLARY OR FOLLICULAR TUMORS</td>\n</tr>\n<tr>\n<td>Stage</td>\n<td>TNM&nbsp;AJCC 7<sup>th</sup> edition</td>\n<td><strong>TNM AJCC 8<sup>th</sup> edition</strong>&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>&lt;45 y</td>\n<td>&nbsp;<strong>&lt;55 y</strong></td>\n</tr>\n<tr>\n<td>\n<p>I</p>\n</td>\n<td>&nbsp;Any T, any N, M0</td>\n<td>&nbsp;-do-</td>\n</tr>\n<tr>\n<td>\n<p>II</p>\n</td>\n<td>&nbsp;Any T, any N, M1</td>\n<td>&nbsp;-do-</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;&ge;45 y</td>\n<td><strong>&nbsp;&gt;55 y</strong></td>\n</tr>\n<tr>\n<td>I</td>\n<td>&nbsp;T1, N0, M0</td>\n<td>&nbsp;<strong>T1-2</strong>, N0, M0</td>\n</tr>\n<tr>\n<td>II</td>\n<td>&nbsp;T2, N0, M0</td>\n<td>\n<p>&nbsp;T1-2, <strong>N1</strong>, M0</p>\n<p><strong>T3</strong>, <strong>any N</strong>, M0</p>\n</td>\n</tr>\n<tr>\n<td>III</td>\n<td>\n<div class=\"page\" title=\"Page 1572\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>T3, N0, M0</p>\n<p>T1&ndash;3, N1a, M0</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td><strong>T4a, any N</strong>, M0</td>\n</tr>\n<tr>\n<td>IV A</td>\n<td>\n<p>T4a, N0-1a, M0</p>\n<p>T1-4a, N1b, M0</p>\n</td>\n<td>&nbsp;<strong>T4b, any N</strong>, M0</td>\n</tr>\n<tr>\n<td>&nbsp;IV B</td>\n<td>&nbsp;T4b, any N, M0</td>\n<td>&nbsp;<strong>any T, any N, M1&nbsp;</strong></td>\n</tr>\n<tr>\n<td>\n<p>IV C</p>\n</td>\n<td>\n<p>Any T, any N, M1</p>\n</td>\n<td>\n<p><strong>- deleted-</strong></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\">MEDULLARY THYROID CANCER&nbsp;</td>\n</tr>\n<tr>\n<td>Stage</td>\n<td>TNM&nbsp;AJCC 7<sup>th</sup> edition</td>\n<td><strong>TNM AJCC 8<sup>th</sup> edition</strong>&nbsp;</td>\n</tr>\n<tr>\n<td>I</td>\n<td>T1, N0, M0</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>II</td>\n<td>T2&ndash;3, N0, M0</td>\n<td>-do- &nbsp;</td>\n</tr>\n<tr>\n<td>III</td>\n<td>T1&ndash;3, N1a, M0</td>\n<td>-do-&nbsp;</td>\n</tr>\n<tr>\n<td>IV A</td>\n<td>\n<p>T4a, any N, M0;</p>\n<p>T1-3, N1b, M0&nbsp;</p>\n</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>IV B</td>\n<td>&nbsp;T4b, any N, M0</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>IV C</td>\n<td>&nbsp;Any T, any N, M1</td>\n<td>-do-</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><p><strong>Anaplastic :</strong></p>\n<ul>\n<li>Unlike previous editions where all anaplastic thyroid cancers were classified as T4 disease, anaplastic cancers now use the<strong> same T&nbsp; definitions as differentiated thyroid cancer</strong>.</li>\n<li><strong>Intrathyroidal disease</strong> (<strong>T1-3a)</strong> is stage <strong>IVA</strong></li>\n<li><strong>Gross extrathyroidal extension</strong>(<strong>T3b,T4)</strong> or <strong>cervical lymph node metastases (N1)</strong> is stage <strong>IVB</strong></li>\n<li><strong>Distant metastases</strong> <strong>(M1)</strong> are stage <strong>IVC</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td colspan=\"3\">\n<p>ANAPLASTIC CANCER</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Stage</p>\n</td>\n<td>\n<p>TNM&nbsp;AJCC 7<sup>th</sup> edition</p>\n</td>\n<td>&nbsp;<strong>TNM AJCC 8<sup>th</sup>edition</strong>&nbsp; &nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>IV A</p>\n</td>\n<td>&nbsp;T4a, Any N, M0</td>\n<td>&nbsp;<strong>T1-3a, N0,</strong> M0</td>\n</tr>\n<tr>\n<td>&nbsp;IV B</td>\n<td>&nbsp;T4b, Any N, M0</td>\n<td>\n<p>T1-3a, <strong>N1</strong>, M0;</p>\n<p><strong>T3b</strong>, Any N, M0;</p>\n<p><strong>T4</strong>, Any N, M0</p>\n</td>\n</tr>\n<tr>\n<td>IV C</td>\n<td>&nbsp;Any T, Any N, M1</td>\n<td>&nbsp;-do-</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Papillary thyroid carcinoma</h3><p>Papillary carcinoma is the <strong>most common</strong> thyroid carcinoma. It is most common in <strong>iodine sufficient areas</strong>, <strong>children</strong> and in those exposed to <strong>ionizing</strong>&nbsp;<strong>radiation.</strong>&nbsp;</p>\n<p>The mean age of presentation is<strong> 3rd-4th</strong> decade and is more common in <strong>women</strong> than men (2:1).&nbsp;<strong>Dysphagia</strong>, <strong>dysphonia</strong> and <strong>dyspnea</strong> are associated with local invasion.</p>\n<p>It usually presents as a&nbsp;<strong>cold nodule </strong>on the scan. Histological findings include:</p>\n<ul>\n<li>Branching&nbsp;papillae&nbsp;</li>\n<li>Follicles with the fibrovascular stalk</li>\n<li><strong>Psammoma bodies</strong></li>\n<li>Nuclear changes-&nbsp;\n<ul>\n<li>Optically clear -&nbsp;Ground glass&nbsp;or&nbsp;<strong>Orphan Annie eye nuclei</strong></li>\n<li>Pseudo-inclusions</li>\n<li>Nuclear grooves.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Lymph</strong> node metastasis is common.&nbsp;<strong>Lateral aberrant thyroid</strong> denotes a cervical lymph node invaded by papillary carcinoma. The most common sites of metastasis : <strong>lung</strong> &gt; liver &gt; bone &gt; brain.</p>\n<p>It has an <strong>excellent prognosis</strong>, with a 10-year survival rate in excess of 95%.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/811b6d4f62e946e1bf6b03dea8a607f1.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4265",
      "difficulty": "medium"
    },
    {
      "text": "A 28-year-old female patient presents to the OPD with complaints of pain in the right knee for the past few months. On examination, there is tenderness in the affected part with a reduced range of motion. A radiographic study revealed a solitary lytic lesion at the distal end of the femur and the microscopic appearance of the lesion is shown below. Which of the following is not an x-ray finding in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Soap bubble appearance"
        },
        {
          "id": 2,
          "text": "It is usually radiopaque"
        },
        {
          "id": 3,
          "text": "Expansion of the overlying cortex"
        },
        {
          "id": 4,
          "text": "No calcification within the tumor"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical history and microscopic appearance are suggestive of <strong>osteoclastoma or giant cell tumor</strong>&nbsp;and they are <strong>purely radiolucent</strong>.</p>\n<p>Microscopically they are composed of <strong>mononuclear cells with macrophages. </strong>They are more common between the age of 20-40 and typically affect the metaphyses of long bones with a preponderance for the <strong>distal femur</strong>, proximal tibia, distal radius and proximal humerus.</p>\n<p>Important X-ray features of a GCT:</p>\n<ul>\n<li>A solitary, possibly lobulated, lytic lesion in the epiphysis</li>\n<li>Eccentric location, most often subchondral</li>\n<li>Expansion of the overlying cortex</li>\n<li>Soap bubble appearance - The tumor is homogeneously lytic with trabeculae of the remnants of bone traversing it, giving it a loculated appearance called soap bubble appearance</li>\n<li>No calcification within the tumor</li>\n<li>No or minimal reactive sclerosis around the tumor.</li>\n</ul>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/901df9b043104a59a046d880f3f1440dx720x912.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>The treatment of choice for GCT is extended <strong>curettage</strong> and <strong>bone grafting</strong>.</p>\n<ul>\n<li aria-level=\"1\">GCT in the relatively insignificant bone like distal ulna, clavicle, proximal fibula is treated by<strong> resection</strong> without reconstruction.</li>\n<li aria-level=\"1\"><strong>Bisphosphonates</strong> have been shown to reduce the proliferation of osteoclasts and hence have been shown to stabilize local and metastatic disease.</li>\n<li aria-level=\"1\"><strong>Radiation</strong> can be used for spinal or sacral tumors.</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/cc058b9b197b4bc79cdf304a61abf51d.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9794",
      "difficulty": "medium"
    },
    {
      "text": "A 50-year-old man had multiple nodular skin lesions for the past 5 years. Previous investigations showed CD 4 T helper cells in these lesions. He has been using topical steroids for its management. He now presents with rapid onset diffuse erythema of the skin. Which of the following will be seen in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Staphylococcal skin infection"
        },
        {
          "id": 2,
          "text": "Increased CD 8 T cells in the skin"
        },
        {
          "id": 3,
          "text": "Abnormal T cells with cerebriform nucleus in blood"
        },
        {
          "id": 4,
          "text": "Increased mast cells around dermal blood vessels"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given scenario describes the development of <strong>Sezary syndrome in a patient with mycosis fungoides</strong>. This syndrome shows the presence of <strong>abnormal T cells with cerebriform nucleii (Sezary cells)</strong> in the <strong>blood</strong>.</p>\n<p>Mycosis fungoides is <strong>cutaneous T cell lymphoma</strong> (CD4+ Helper T cells) which usually stays confined to the skin. It can disseminate into blood which is known as Sezary syndrome. It presents as diffuse erythema of the skin (<strong>erythroderma</strong>).</p>\n<p>Mycoses fungoides presents as scaly red-brown patches, raised scaling plaques, and fungating nodules. It passes through 3 phases:</p>\n<ul>\n<li><strong>Inflammatory pre-mycotic</strong> <strong>phase</strong>- eczema like lesions</li>\n<li><strong>Plaque phase</strong>- raised plaques are seen</li>\n<li><strong>Tumor phase</strong>- multiple tumor nodules indicating systemic spread</li>\n</ul>\n<p>The given image shows mycosis fungoides:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0e1d56c4bcc54276b58a639e470beb1dx800x600.JPEG\" alt=\"Explanation Image\"><p>Sezary syndrome occurs when malignant T cells from mycoses fungoides are seeded into blood. This leads to diffuse erythema and scaling of the entire body surface. The skin lesions in case of Sezary syndrome rarely reach tumefaction phase.</p>\n<p>The given image shows erythrodermic sezary syndrome:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0a7fb8b957884484aae491468a39c9bax800x1082.JPEG\" alt=\"Explanation Image\"><p>The given image shows Sezary cells:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/544e1c348f774596b9eef59494f54620x800x600.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD8139",
      "difficulty": "medium"
    },
    {
      "text": "A 65-year-old male presents with complaints of easy fatigability, weight loss, and an evening rise in temperature. Investigations reveal pancytopenia. The bone marrow aspirate of a patient is shown in the image given below. Cytogenetic studies revealed the presence of t(15:17). This subtype of disease is associated with which of the following conditions?",
      "choices": [
        {
          "id": 1,
          "text": "Chloroma"
        },
        {
          "id": 2,
          "text": "DIC"
        },
        {
          "id": 3,
          "text": "Leukemia cutis"
        },
        {
          "id": 4,
          "text": "Down's syndrome"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In the given clinical scenario, the presence of <strong>Auer rods</strong> on bone marrow aspirates and <strong>t(15:17)</strong> on cytogenic studies points towards the diagnosis of <strong>AML-M3. DIC</strong> is most <strong>commonly associated</strong> with AML-M3.</p>\n<p><strong>Peripheral smear (WBC):</strong></p>\n<p><strong>1) Acute myeloid leukemia</strong></p>\n<p>Acute myeloid leukemia is a tumor of hematopoietic progenitors caused by acquired oncogenic mutations. This leads to the accumulation of immature myeloid blasts in the marrow resulting in marrow failure and complications related to anemia, thrombocytopenia, and neutropenia.</p>\n<ul>\n<li>Bone marrow/peripheral smear shows a large, uniform population of cells <strong>(myeloblasts)</strong> with prominent nucleoli (<strong>yellow arrow</strong>). It shows the presence of primary cytoplasmic granules</li>\n<li><strong>Auer rods: Needle-shaped</strong> azurophilic intracytoplasmic <strong>inclusion bodies(black arrow</strong>) particularly seen in <strong>acute promyelocytic leukemia</strong> (AML M3) with <strong>t(15;17).</strong></li>\n</ul>\n<p> </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2d5a413779f1468dac68342811b4bb48x352x512.JPEG\" alt=\"Explanation Image\"><p><strong>2) Acute lymphoblastic leukemia (ALL)</strong> </p>\n<p>ALL arises from immature B (pre-B) or T (pre-T) cells called <strong>lymphoblasts. Immunohistochemistry</strong> for terminal deoxynucleotidyl transferase <strong>(TdT)</strong> is positive in pre-B and pre-T lymphoblasts. Peripheral smear shows lymphoblasts that have condensed chromatin, less conspicuous nucleoli, and scant basophilic cytoplasm which lacks granules as shown below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9788bbf7ca0b4bf092835c95fb655bdex720x820.JPEG\" alt=\"Explanation Image\"><p><strong>3) Chronic lymphocytic leukemia (CLL)</strong></p>\n<p>CLL is associated with the <strong>deletions</strong> of 13q, 11q, 17q, and trisomy 12q. Lymph nodes are diffusely effaced by small lymphocytes with <strong>proliferation centers</strong>. The peripheral smear shows small round lymphocytes with scant cytoplasm and <strong>smudge cells</strong> as seen below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3ea50c0952f847bb8c23e2a4ef34546ax355x512.JPEG\" alt=\"Explanation Image\"><p><strong>4) Chronic myeloid leukemia (CML)</strong></p>\n<p>CML is characterized by the presence of a<strong> Philadelphia chromosome </strong>resulting from reciprocal translocation t(9;22) forming the<strong> BCR-ABL fusion </strong>gene. They have hypercellular marrow due to a massively increased number of maturing granulocytic precursors. The image below shows peripheral smear findings of CML with neutrophils, myelocytes, metamyelocytes, and band cells.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a07b0a55e0f04edfaefe10bde3ca73c7x1280x960.JPEG\" alt=\"Explanation Image\"><p>Other options</p>\n<p>Option A: Chloroma( localised soft tissue mass composed of extramedullary proliferation of primitive cells of myeloid lineage) is commonly associated with AML-M2. It can also be seen in AML-M4 and M5</p>\n<p>Option C: Leukemia cutis(leukemic infiltration of the epidermis, the dermis, and the subcutaneous tissue.). is associated with AML-M4 and M5.</p>\n<p>Option D: Down's syndrome is associated with AML-M7.</p>\n<p> </p><hr><h3>Related Pearl: FAB classification</h3><table>\n<tbody>\n<tr>\n<td><strong>FAB classification</strong></td>\n<td><strong>High-Yield points</strong></td>\n</tr>\n<tr>\n<td>M0-minimal differentiation</td>\n<td>-</td>\n</tr>\n<tr>\n<td>M1-without maturation</td>\n<td>-</td>\n</tr>\n<tr>\n<td>M2 - with maturation</td>\n<td>\n<ul>\n<li>Most common</li>\n<li>t(8,21)</li>\n<li>Chloromas</li>\n<li>Good prognosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M3 - promyelocytic</td>\n<td>\n<ul>\n<li>Young-good prognosis</li>\n<li>t(15,17)-intermediate</li>\n<li>Auer rods</li>\n<li>DIC</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M4 - myelomonocytic</td>\n<td>\n<ul>\n<li>inv 16</li>\n<li>t(16,16)</li>\n<li>Eosinophilia</li>\n<li>Gingival hyperplasia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>M5a - monoblastic</p>\n<p>M5b - monocytic</p>\n</td>\n<td>\n<ul>\n<li>Organ infiltration</li>\n<li>Gingival hyperplasia</li>\n<li>Increased WBC count, fever</li>\n<li>Sweet syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M6 - erythroid</td>\n<td>\n<ul>\n<li>Therapy related</li>\n<li>Erythemic myelosis, Di&nbsp;Guglielmo disease</li>\n<li>Poor prognosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M7 - megakaryocytic</td>\n<td>\n<ul>\n<li>CD 41/61</li>\n<li>Bad prognosis</li>\n<li>Down syndrome (good prognosis)</li>\n<li>Bone marrow fibrosis (increased PDGF)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b0434874a75a4f368cec836760ac1c98.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0295",
      "difficulty": "medium"
    },
    {
      "text": "A young female patient was brought to the emergency room with severe gastrointestinal bleeding. The attenders inform the duty doctor that the patient was on warfarin medications. Her blood group is unknown. The duty doctor can transfuse fresh frozen plasma (FFP) from which of the following blood groups?",
      "choices": [
        {
          "id": 1,
          "text": "O"
        },
        {
          "id": 2,
          "text": "AB"
        },
        {
          "id": 3,
          "text": "A"
        },
        {
          "id": 4,
          "text": "B"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong><span data-preserver-spaces=\"true\">AB fresh frozen plasma&nbsp;</span></strong>(FFP)<span data-preserver-spaces=\"true\">&nbsp;is given when uncross-matched plasma is needed as in the above case, wherein the blood group of the patient is not known.</span></p>\n<p><span data-preserver-spaces=\"true\">It is to be noted that in cases of <strong>active bleeding </strong>in a patient on warfarin therapy, prothrombin complex concentrate (PCC) is recommended over FFP. In case PCC is not available, FFP is used as in the above case.</span></p>\n<p>FFP is plasma prepared from whole blood, either from the primary centrifugation of whole blood into red cells and plasma or from the secondary centrifugation of platelet-rich plasma. The plasma is rapidly frozen to &ndash;25&deg;C or colder within 8 hours of collection and contains normal plasma levels of stable clotting factors, albumin, immunoglobulin, and Factor VIII at a level of at least 70% of normal fresh plasma<strong>.</strong></p>\n<p>Each unit of issued FFP contains a quantity of&nbsp;<strong>200-300 mL</strong>.</p>\n<p>FFP is capable of transmitting any agent present in cells or plasma, which was undetected by routine screening including HIV, hepatitis B and C, syphilis, and malaria.</p>\n<p><strong>Definite indications</strong>&nbsp;of FFP transfusion:</p>\n<ul>\n<li>Replacement of a <strong>single coagulation factor deficiency</strong>, where a specific or combined factor concentrate is unavailable or contraindicated.</li>\n<li>Immediate <strong>reversal of warfarin</strong> effect where <strong>prothrombin complex</strong> concentrate is <strong>unavailable.</strong></li>\n<li>Thrombotic thrombocytopenic purpura.</li>\n<li>Inherited coagulation inhibitor deficiencies where the specific concentrate is unavailable.</li>\n<li>C1 esterase inhibitor deficiency where the specific concentrate is unavailable</li>\n</ul>\n<p><span data-preserver-spaces=\"true\">In an emergency, if crossmatched blood is unavailable:</span></p>\n<ul>\n<li><strong><span data-preserver-spaces=\"true\">Type O negative pRBCs</span></strong><span data-preserver-spaces=\"true\">&nbsp;are indicated for patients with exsanguinating hemorrhage because it lacks the A and B and Rh antigens, and thus, it cannot be hemolyzed by anti-A, anti-B, or anti-D antibodies in the recipient&rsquo;s blood.</span></li>\n<li><strong><span data-preserver-spaces=\"true\">AB plasma</span></strong><span data-preserver-spaces=\"true\">&nbsp;is given when uncross-matched plasma is needed because it <strong>does not contain antibodies against any antigens on RBCs</strong>.</span></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4983",
      "difficulty": "medium"
    },
    {
      "text": "A 14-year-old boy has frequent episodes of facial edema around his lips. It usually occurs after an emotional stressor. He also has a family history of similar conditions. Which of the following is the main mediator of these symptoms?",
      "choices": [
        {
          "id": 1,
          "text": "Leukotrienes"
        },
        {
          "id": 2,
          "text": "Bradykinin"
        },
        {
          "id": 3,
          "text": "Prostaglandins"
        },
        {
          "id": 4,
          "text": "Histamine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of <strong>hereditary angioedema. </strong>The main inflammatory mediator responsible for these symptoms is <strong>bradykinin</strong>.</p>\n<p>Bradykinin is an inflammatory mediator formed by the cleavage of kininogen, in the presence of the enzyme kallikrein. Bradykinin has the following<strong> effects:</strong></p>\n<ul>\n<li>Increases the vascular permeability</li>\n<li>Causes contraction of smooth muscle</li>\n<li>Dilates the blood vessel </li>\n<li>Mediates pain</li>\n</ul>\n<p>Hereditary angioedema is an autosomal dominant condition characterized by a <strong>deficiency</strong> of <strong>C1 esterase inhibitors.</strong> C1 esterase inhibitors usually target proteases like C1r and C1s, factor XII and the kallikrein system. Therefore, its deficiency leads to unregulated activation of kallikrein, leading to <strong>increased bradykinin.</strong></p>\n<p><strong>Features</strong> of the condition include swelling of the skin and mucosal surfaces, nausea, vomiting, and diarrhea. They may be aggravated after minor trauma or emotional stressor. The condition can be<strong> treated</strong> by giving C1 inhibitor concentrates from human plasma. </p>\n<p>Option D: histamine is implicated as a mediator of angioedema in anaphylaxis. However, the main mediator in Heriditory Angioedema is bradykinnin and therefore the correct answer.</p><hr><h3>Related Pearl: Various actions of Principal Mediators of Inflammation</h3><table>\n<tbody>\n<tr>\n<td>Histamine</td>\n<td>Vasodilation, increased vascular permeability, endothelial activation</td>\n</tr>\n<tr>\n<td>Prostaglandins</td>\n<td>Vasodilation, pain, fever</td>\n</tr>\n<tr>\n<td>Leukotrienes</td>\n<td>Increased vascular permeability, chemotaxis, leukocyte adhesion, and activation</td>\n</tr>\n<tr>\n<td>Cytokines (TNF, IL-1, IL-6)</td>\n<td>\n<p>Local: endothelial activation (expression of adhesion molecules).</p>\n<p>Systemic: fever, metabolic abnormalities, hypotension (shock)</p>\n</td>\n</tr>\n<tr>\n<td>Chemokines</td>\n<td>Chemotaxis, leukocyte activation</td>\n</tr>\n<tr>\n<td>Platelet-activating factor</td>\n<td>Vasoconstriction, Vasodilation (at low concentration), increased vascular permeability, leukocyte adhesion, chemotaxis, degranulation, oxidative burst</td>\n</tr>\n<tr>\n<td>Complement</td>\n<td>Leukocyte chemotaxis and activation, direct target killing (membrane attack complex), vasodilation (mast cell stimulation)</td>\n</tr>\n<tr>\n<td>Kinins</td>\n<td>Increased vascular permeability, smooth muscle contraction, vasodilation, pain</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note: Thromboxane A2 (TXA2) is a prostaglandin, which is a potent <strong>vasoconstrictor</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD1699",
      "difficulty": "medium"
    },
    {
      "text": "A 53-year-old female patient is diagnosed with breast cancer. The findings of immunohistochemistry staining are shown in the image given below. Identify the subtype of breast cancer based on these findings.",
      "choices": [
        {
          "id": 1,
          "text": "Triple negative"
        },
        {
          "id": 2,
          "text": "Luminal type A"
        },
        {
          "id": 3,
          "text": "Luminal type B"
        },
        {
          "id": 4,
          "text": "Basal type"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The above image shows immunohistochemistry staining positive for ER, PR, and HER2 receptors, which is <strong>triple</strong> <strong>positive</strong> or <strong>luminal type B&nbsp;</strong>of breast cancer.</p>\n<p><strong>Immunohistochemistry staining:</strong></p>\n<p>Positive staining is indicated by the presence of brown-colored tissue.</p>\n<ul>\n<li>The <strong>estrogen receptor (ER)</strong>&nbsp;and<strong>&nbsp;progesterone receptor (PR)</strong>&nbsp;are both nuclear receptors; hence, the nucleus is stained brown if positive.</li>\n<li>The<strong>&nbsp;human epidermal growth factor receptor type 2 (HER2)</strong>&nbsp;is a membrane receptor; hence the cell membrane is stained brown if positive.</li>\n</ul>\n<p>The image below shows positive and negative staining for ER, PR, and HER2.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2644a3a7e0ce4bf38e37ad36d717dd33x243x199.JPEG\" alt=\"Explanation Image\"><table>\n<tbody>\n<tr>\n<td><strong>Molecular subtypes</strong>&nbsp;</td>\n<td><strong>ER</strong></td>\n<td><strong>PR</strong></td>\n<td><strong>&nbsp;HER2</strong></td>\n<td><strong>Ki-67</strong></td>\n<td><strong>Cytokeratin 5 and 6</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Luminal A</strong></p>\n<p>(Most common type and has the best prognosis)&nbsp;</p>\n</td>\n<td>+ve</td>\n<td>+ve</td>\n<td>-ve</td>\n<td>Low</td>\n<td>-ve</td>\n</tr>\n<tr>\n<td><strong>Luminal B</strong></td>\n<td>+ve</td>\n<td>+ve</td>\n<td>+ve</td>\n<td>High</td>\n<td>-ve</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>+ve</td>\n<td>+ve</td>\n<td>+ve</td>\n<td>Any</td>\n<td>-ve</td>\n</tr>\n<tr>\n<td><strong>HER2 enriched</strong></td>\n<td>-ve</td>\n<td>-ve</td>\n<td>+ve</td>\n<td>Any</td>\n<td>-ve</td>\n</tr>\n<tr>\n<td>\n<p><strong>Basal-like or Triple-negative breast cancer</strong></p>\n<p>(Aggressive, has worst prognosis but shows good response to chemotherapy, high&nbsp;PCR rates)&nbsp;</p>\n</td>\n<td>-ve</td>\n<td>-ve</td>\n<td>-ve</td>\n<td>Any</td>\n<td>+ve</td>\n</tr>\n<tr>\n<td>\n<p><strong>Unclassified</strong>, now also known as&nbsp;<strong>Claudin-low&nbsp;</strong></p>\n</td>\n<td>-ve</td>\n<td>-ve</td>\n<td>-ve</td>\n<td>Any</td>\n<td>-ve</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Molecular classification of breast cancer</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Molecular subtypes&nbsp;</strong></td>\n<td>\n<p><strong>Receptor status </strong></p>\n</td>\n<td><strong>Histological subtypes</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Luminal A type&nbsp;</strong></p>\n<p><strong>(most common,&nbsp;</strong>best prognosis)</p>\n<p>Mutated gene-&nbsp;BRCA 2</p>\n</td>\n<td>\n<p>ER/PR-&nbsp;+ve</p>\n<p>Her2- -ve</p>\n<p><strong>Ki-67-&nbsp;</strong></p>\n<p><strong>&lt;14% (low)</strong></p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 1069\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Lobular carcinoma</p>\n<p>Mucinous carcinoma</p>\n<p>Tubular carcinoma</p>\n<p>Papillary carcinoma</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Luminal B type (HER2/neu negative)</strong></p>\n<p>Mutated gene-&nbsp;BRCA 2&nbsp;</p>\n</td>\n<td>\n<p>ER/PR-&nbsp;+ve</p>\n<p>Her2- -ve</p>\n<p><strong>Ki-67-&nbsp;</strong></p>\n<p><strong>&gt;14% (high)</strong></p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 1064\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Poorly differentiated, lobular-carcinoma</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Luminal B type (HER2 positive)</strong></p>\n</td>\n<td>\n<p>ER/PR-&nbsp;+ve</p>\n<p>Her2- +ve</p>\n<p><strong>Ki-67-&nbsp;</strong></p>\n<p><strong>variable</strong></p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>HER2 enriched</strong></p>\n<p>Mutated gene-&nbsp;TP53</p>\n</td>\n<td>\n<p>ER/PR-&nbsp;-ve</p>\n<p>Her2- +ve</p>\n<p><strong>Ki-67-&nbsp;</strong></p>\n<p><strong>High&nbsp;</strong></p>\n</td>\n<td>\n<p>Apocrine carcinoma</p>\n<p>Micro-papillary carcinoma</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Basal type&nbsp;</strong><strong>(Triple-negative)</strong></p>\n<p>Mutated gene-&nbsp;BRCA 1</p>\n</td>\n<td>\n<p>ER/PR-&nbsp;-ve</p>\n<p>Her2- -ve</p>\n<p><strong>Ki-67-&nbsp;</strong></p>\n<p><strong>High</strong></p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 1064\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Medullary carcinoma</p>\n<p>Adenoid cystic carcinoma</p>\n<p>Secretory carcinoma</p>\n<p>Metaplastic carcinoma</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Update: <strong>Claudin low-molecular subtype</strong>&nbsp;is a triple-negative breast cancer with low expression of E-cadherin, with a poor prognosis. It is frequently associated with lymphocyte infiltration.</p>\n<p>Almost all breast malignancies are adenocarcinomas and based on the expression of estrogen receptor and HER2 can be divided into three major biologic subgroups:</p>\n<ul>\n<li><strong>ER-positive HER2-negative tumors&nbsp;</strong>(50% to 65% of tumors) &ndash; range from well-differentiated cancers with low proliferative rates and few chromosomal changes to poorly differentiated cancers with high proliferative rates and large numbers of chromosomal rearrangements. All of these cancers express ER.</li>\n<li><strong>HER2-positive cancers - </strong>10% to 20% of tumors, which may either be ER-positive or ER-negative.</li>\n<li><strong>ER-negative, HER2-negative carcinomas&nbsp;</strong>(triple-negative or basal-like)- are characterized by genomic instability, a high proliferative rate, and expression of many proteins typical of myoepithelial cells (e.g., basal keratins).</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Defining Features</strong></p>\n</td>\n<td>\n<p><strong>ER-positive, HER2- negative</strong></p>\n&nbsp;&nbsp;</td>\n<td>&nbsp;</td>\n<td>\n<p><strong>HER2- Positive (ER- positive or negative)</strong></p>\n</td>\n<td>\n<p><strong>ER- negative</strong></p>\n<p><strong>HER2- negative</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Frequency</p>\n</td>\n<td>\n<p>~40-55% (Low proliferation)</p>\n</td>\n<td>\n<p>~10% (High proliferation)</p>\n</td>\n<td>\n<p>~20%</p>\n</td>\n<td>\n<p>~15%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Included special histologic types</p>\n</td>\n<td>\n<p>Well or moderately differentiated lobular, tubular, mucinous</p>\n</td>\n<td>\n<p>Poorly differentiated lobular</p>\n</td>\n<td>\n<p>Some apocrine</p>\n</td>\n<td>\n<p>Medullary, adenoid cystic, secretory, metaplastic</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Typical patient groups</p>\n</td>\n<td>\n<p>Older women, men, cancers detected by mammographic screening</p>\n</td>\n<td>\n<p><em>BRCA2</em> mutation carriers</p>\n</td>\n<td>\n<p>Young women, non-white women, <em>TP53</em> mutation carrier (ER-positive)</p>\n</td>\n<td>\n<p>Young women, <em>BRCA1 </em>mutation carriers, African American and Hispanic women</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/3c096a70f9324b5bb4a61f64eb3b59be.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7070",
      "difficulty": "medium"
    }
  ]
}